Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancerKyle C. Strickland, Panagiotis A. Konstantinopoulos|Oncotarget|2016Cited by 616
A single-cell landscape of high-grade serous ovarian cancerBenjamin Izar, Aviv Regev, Itay Tirosh et al.|Nature Medicine|2020Cited by 522
Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian CancerPanagiotis A. Konstantinopoulos, Stephen A. Cannistra, Dimitrios Spentzos et al.|Journal of Clinical Oncology|2010Cited by 488
Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerAnniina Färkkilä, Panagiotis A. Konstantinopoulos, D. Gulhan et al.|Nature Communications|2020Cited by 342
Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian CancerPanagiotis A. Konstantinopoulos, Stephen A. Cannistra, Dimitrios Spentzos et al.|Cancer Research|2011Cited by 266